| ITX-5061 HCl |
1252679-52-9 |
1252679-52-9 |
| SMI-16a |
PIM1/2 KINASE INHIBITOR VI |
587852-28-6 |
| NVS-PAK1-1 |
NVS-PAK1-1 |
1783816-74-9 |
| CPI-444 |
443103-97-7 |
443103-97-7 |
| GNE140 |
(R)-GNE-140 |
2003234-63-5 |
| 4-Piperidinecarbonitrile, 1-[[5-[4-methyl-5-(trifluoromethyl)-3-isoxazolyl]-2-thienyl]carbonyl]- |
1124198-17-9 |
1124198-17-9 |
| Pentanoic acid, 5-[(3-methoxypropyl)pentylamino]-4-[(2-naphthalenylsulfonyl)methyl]-5-oxo- |
137004-80-9 |
137004-80-9 |
| β-Apo-13-carotenone |
β-Apo-13-carotenone |
17974-57-1 |
| Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- |
Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- |
56699-31-1 |
| CDC801 |
192819-27-5 |
192819-27-5 |
| GDP366 |
501698-03-9 |
501698-03-9 |
| EF-5 |
EF-5 |
152721-37-4 |
| Avelumab |
阿维鲁单抗 |
1537032-82-8 |
| SP187 |
615253-61-7 |
615253-61-7 |
| WD2000-012547 |
283172-68-9 |
283172-68-9 |
| BGB-3111 |
1558036-85-3 |
1558036-85-3 |
| 5-Pyrimidinecarboxylic acid, 6-(3,4-difluorophenyl)-1,2,3,6-tetrahydro-4-(methoxymethyl)-2-oxo-1-[[[3-[4-(2-pyridinyl)-1-piperidinyl]propyl]amino]carbonyl]-, methyl ester |
391610-37-0 |
391610-37-0 |
| 4H-1,2,4-Triazole, 3-(2-chloro-4-fluorophenyl)-4-methyl-5-[1-methyl-1-(2,4,6-trifluorophenoxy)ethyl]- |
4H-1,2,4-Triazole, 3-(2-chloro-4-fluorophenyl)-4-methyl-5-[1-methyl-1-(2,4,6-trifluorophenoxy)ethyl]- |
1203956-47-1 |
| 2: PN: US20040072744 SEQID: 2 claimed protein |
389572-87-6 |
389572-87-6 |
| AZP-531 |
1088543-62-7 |
1088543-62-7 |
